The estimated Net Worth of Louis Md Brenner is at least $3.01 million dollars as of 15 November 2021. Louis Brenner owns over 125,582 units of Allena Pharmaceuticals Inc stock worth over $26,312 and over the last 17 years he sold ALNA stock worth over $0. In addition, he makes $2,980,630 as President, Chief Executive Officer et Director at Allena Pharmaceuticals Inc.
Sign up
Louis Brenner ALNA stock SEC Form 4 insiders trading
Louis has made over 11 trades of the Allena Pharmaceuticals Inc stock since 2007, according to the Form 4 filled with the SEC. Most recently he exercised 125,582 units of ALNA stock worth $10,047 on 15 November 2021.
The largest trade he's ever made was exercising 247,932 units of Allena Pharmaceuticals Inc stock on 17 December 2020 worth over $19,835. On average, Louis trades about 20,402 units every 224 days since 2007. As of 15 November 2021 he still owns at least 328,904 units of Allena Pharmaceuticals Inc stock.
You can see the complete history of Louis Brenner stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Louis Brenner biography
Dr. Louis Brenner M.D. serves as President, Chief Executive Officer, Director of the Company. He also served as our Chief Operating Officer from April 2015 to February 2019. Dr. Brenner has more than a decade of industry leadership experience, including pharmaceutical development strategy, regulatory affairs, business development and marketing. From January 2014 to April 2015, Dr. Brenner served as Senior Vice President and Chief Medical Officer at Idera Pharmaceuticals, Inc. (Nasdaq: IDRA). Dr. Brenner served as Chief Medical Officer for Radius Health, Inc. (Nasdaq: RDUS), a biopharmaceutical company, from November 2011 to January 2014. Dr. Brenner has designed, planned and directed successful clinical trials at all stages and in multiple indications. He also serves on the board of directors of Goldfinch Biopharma Inc., a privately held biotechnology company. Dr. Brenner earned a B.S. from Yale University, an M.D. from Duke University and an M.B.A. from Harvard Business School.
What is the salary of Louis Brenner?
As the President, Chief Executive Officer et Director of Allena Pharmaceuticals Inc, the total compensation of Louis Brenner at Allena Pharmaceuticals Inc is $2,980,630. There are no executives at Allena Pharmaceuticals Inc getting paid more.
How old is Louis Brenner?
Louis Brenner is 50, he's been the President, Chief Executive Officer et Director of Allena Pharmaceuticals Inc since 2019. There are 11 older and 2 younger executives at Allena Pharmaceuticals Inc. The oldest executive at Allena Pharmaceuticals Inc is Dr. Alexey L. Margolin, 68, who is the Co-Founder & Chairman.
What's Louis Brenner's mailing address?
Louis's mailing address filed with the SEC is C/O ALLENA PHARMACEUTICALS, INC., ONE NEWTON EXECUTIVE PARK, SUITE 202, NEWTON, MA, 02462.
Insiders trading at Allena Pharmaceuticals Inc
Over the last 7 years, insiders at Allena Pharmaceuticals Inc have traded over $0 worth of Allena Pharmaceuticals Inc stock and bought 1,537,428 units worth $21,523,992 . The most active insiders traders include Andrew A. F. Hack, James N Topper et Harbor Master Investors (Ca.... On average, Allena Pharmaceuticals Inc executives and independent directors trade stock every 134 days with the average trade being worth of $15,887. The most recent stock trade was executed by Louis Md Brenner on 15 November 2021, trading 125,582 units of ALNA stock currently worth $10,047.
What does Allena Pharmaceuticals Inc's logo look like?
Complete history of Louis Brenner stock trades at AMAG Pharmaceuticals, Idera Pharmaceuticals et Allena Pharmaceuticals Inc
Allena Pharmaceuticals Inc executives and stock owners
Allena Pharmaceuticals Inc executives and other stock owners filed with the SEC include:
-
Louis Brenner,
President, Chief Executive Officer, Director -
Edward Wholihan,
Chief Financial Officer -
Dr. Louis Brenner,
Pres, CEO & Director -
Dr. Alexey L. Margolin,
Co-Founder & Chairman -
Alexey Margolin,
Chairman of the Board, Co-Founder -
Geoffrey Swire,
Acting Chief Operating Officer, Interim Principal Operating Officer, Senior Vice President - Corporate Development -
James Topper,
Independent Director -
Gino Santini,
Independent Director -
Andrew Hack,
Independent Director -
Allene Diaz,
Independent Director -
Robert Alexander,
Independent Director -
Ann Miller,
Director -
Stephen Yu,
Sr. VP of Corp. Quality -
Dr. David J. Clark,
Chief Medical Officer -
Alicja Januszewicz Ph.D.,
VP of People & Culture -
Hugh Wight,
Sr. VP of Technical Operations -
Dr. Richard D. Katz,
CFO, Principal Financial Officer & Principal Accounting Officer -
Robert Gallotto,
Co-Founder & Strategic Adviser -
Bio Capital Ii Lp Hbm,
10% owner -
Robert I Tepper,
Director -
Vi, L.L.C.Fhm Vi, L.P.Frazi...,
-
Harbor Master Investors (Ca...,
10% owner -
Venture Partners Vii L.P.De...,
-
Stephen Kraus,
Director -
Rock Ventures Ii, L.P.Third...,
-
Axel Bolte,
Director -
Richard D Katz,
Chief Financial Officer -
Mark J. Fitzpatrick,
Director